Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

HU-243Also known as 7-hydroxy-hexahydrocannabinol-DMH

A cannabinoid radioligand of extreme affinity (KD 45 pM), listed by name as a narcotic in France.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₅H₄₀O₃

CAS 140835-14-9

Family
Synthetic CB receptor agonistResearch ligand or medicine
Molar mass
388.60 g/mol

Updated on

In plain terms

HU-243 is a laboratory cannabinoid with an extreme affinity for the cannabis receptor, described in 1992 as a probe: its radioactive version was used to measure this receptor. It is not meant to be consumed, and it is classified as a narcotic in France.

Receptors and activity

Target network

CB1AgonistKd = 0 nM · not specified in the abstractbinding of the tritiated ligand to the cannabinoid receptor; precursor Ki 0.18 nM, CP-55,940 2.0 nM in the same study
  • Activates

The lower the cited value, the closer the target sits to HU-243: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of HU-243.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1AgonistKd = 0 nM · not specified in the abstract100 out of 100

    Devane et al. 1992, J Med Chem (new tab) · binding of the tritiated ligand to the cannabinoid receptor; precursor Ki 0.18 nM, CP-55,940 2.0 nM in the same study

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

HU-243 is a synthetic cannabimimetic agonist of extreme affinity, described in 1992 by Devane, Breuer, Sheskin, Järbe, Eisen and Mechoulam as a « probe » of the cannabinoid receptor. It is the hexahydro analogue of HU-210, which the authors presented as the most potent cannabimimetic substance known at the time; they isolate its equatorial epimer. Its dissociation constant (KD) at the cannabinoid receptor is 45 pM, against a Ki of 180 pM for the unsaturated precursor and 2.0 nM for CP-55,940. In the Δ1-THC discrimination test in pigeons, its ED50 is 0.002 mg/kg at 4.5 h, at the potency level of the precursor. Its tritiated version served as a probe of the receptor. No human data were found.

History

Source
A wholly synthetic compound, absent from cannabis and from every living organism, described in 1992 by Devane, Breuer, Sheskin, Järbe, Eisen and Mechoulam as a probe of the cannabinoid receptor, in tritiated form (Devane et al. 1992). No report of circulation outside the laboratory was found in the sources consulted.

Origin

Laboratory synthesis

No biological pathway: HU-243 is entirely synthetic; it is the hexahydro analogue, with a 1,1-dimethylheptyl chain and a hydroxymethyl group at position 9, of the cannabinoid HU-210.

Classification

Family, origin and source verification

Family

Synthetic CB receptor agonist › Research ligand or medicine

Class

classical

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

HU-243 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

Common name
HU-243 (7-hydroxy-hexahydrocannabinol-DMH)
IUPAC name
(6aR,9R,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol
Other names
HU-243 · AM-4056 · 7-hydroxy-hexahydrocannabinol-DMH

Identifiers

Formula
C₂₅H₄₀O₃
CAS
140835-14-9
PubChem CID
5311171(new tab)
InChIKey
MVEVPDCVOXJVBD-MISYRCLQSA-N
SMILES
CCCCCCC(C)(C)C1=CC(=C2[C@@H]3C[C@@H](CC[C@H]3C(OC2=C1)(C)C)CO)O

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.